UK-BioNTech partnership for mRNA cancer vaccines
Lancet Oncol
.
2023 Aug;24(8):846.
doi: 10.1016/S1470-2045(23)00339-X.
Epub 2023 Jul 13.
Author
Emma Wilkinson
PMID:
37454666
DOI:
10.1016/S1470-2045(23)00339-X
No abstract available
Publication types
News
MeSH terms
Cancer Vaccines* / therapeutic use
Humans
Neoplasms* / genetics
Neoplasms* / therapy
RNA, Messenger
United Kingdom
Substances
Cancer Vaccines
RNA, Messenger